Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal.

Huyse T, Van den Broeck F, Jombart T, Webster BL, Diaw O, Volckaert FA, Balloux F, Rollinson D, Polman K.

Infect Genet Evol. 2013 Aug;18:100-5. doi: 10.1016/j.meegid.2013.05.007. Epub 2013 May 15.

PMID:
23684792
2.

Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.

Webster BL, Diaw OT, Seye MM, Faye DS, Stothard JR, Sousa-Figueiredo JC, Rollinson D.

Acta Trop. 2013 Nov;128(2):292-302. doi: 10.1016/j.actatropica.2012.09.010. Epub 2012 Sep 26.

PMID:
23022016
3.

Reductions in genetic diversity of Schistosoma mansoni populations under chemotherapeutic pressure: the effect of sampling approach and parasite population definition.

French MD, Churcher TS, Basáñez MG, Norton AJ, Lwambo NJ, Webster JP.

Acta Trop. 2013 Nov;128(2):196-205. doi: 10.1016/j.actatropica.2012.03.001. Epub 2012 Mar 15. Review.

PMID:
22440199
4.

Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.

Barakat R, El Morshedy H.

Parasitology. 2011 Apr;138(4):440-6. doi: 10.1017/S003118201000154X. Epub 2010 Nov 16.

PMID:
21078223
5.

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.

Pinto-Almeida A, Mendes T, Armada A, Belo S, Carrilho E, Viveiros M, Afonso A.

PLoS One. 2015 Oct 7;10(10):e0140147. doi: 10.1371/journal.pone.0140147. eCollection 2015.

6.

Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.

Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ.

Am J Trop Med Hyg. 1995 Jul;53(1):61-2.

PMID:
7625534
7.

Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.

Tchuem Tchuenté LA, Momo SC, Stothard JR, Rollinson D.

Acta Trop. 2013 Nov;128(2):275-83. doi: 10.1016/j.actatropica.2013.06.007. Epub 2013 Jun 20.

PMID:
23791803
8.

Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.

Coeli R, Baba EH, Araujo N, Coelho PM, Oliveira G.

PLoS Negl Trop Dis. 2013 Dec 19;7(12):e2596. doi: 10.1371/journal.pntd.0002596. eCollection 2013.

9.

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.

Bustinduy AL, Waterhouse D, de Sousa-Figueiredo JC, Roberts SA, Atuhaire A, Van Dam GJ, Corstjens PL, Scott JT, Stanton MC, Kabatereine NB, Ward S, Hope WW, Stothard JR.

MBio. 2016 Aug 9;7(4). pii: e00227-16. doi: 10.1128/mBio.00227-16.

10.

Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence.

Gryseels B, Mbaye A, De Vlas SJ, Stelma FF, Guissé F, Van Lieshout L, Faye D, Diop M, Ly A, Tchuem-Tchuenté LA, Engels D, Polman K.

Trop Med Int Health. 2001 Nov;6(11):864-73.

11.

Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni.

Liang YS, Wang W, Dai JR, Li HJ, Tao YH, Zhang JF, Li W, Zhu YC, Coles GC, Doenhoff MJ.

J Helminthol. 2010 Jun;84(2):202-7. doi: 10.1017/S0022149X0999054X. Epub 2009 Sep 18.

PMID:
19765323
12.

Efficacy of praziquantel against Schistosoma mansoni in northern Senegal.

Picquet M, Vercruysse J, Shaw DJ, Diop M, Ly A.

Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):90-3.

PMID:
9692165
13.

Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial.

Nalugwa A, Nuwaha F, Tukahebwa EM, Olsen A.

PLoS Negl Trop Dis. 2015 May 26;9(5):e0003796. doi: 10.1371/journal.pntd.0003796. eCollection 2015 May.

14.

Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.

Garba A, Lamine MS, Barkiré N, Djibo A, Sofo B, Gouvras AN, Labbo R, Sebangou H, Webster JP, Fenwick A, Utzinger J.

Acta Trop. 2013 Nov;128(2):334-44. doi: 10.1016/j.actatropica.2012.08.008. Epub 2012 Aug 23.

PMID:
22940014
15.

Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.

Lotfy WM, Hishmat MG, El Nashar AS, Abu El Einin HM.

Pharm Biol. 2015 Aug;53(8):1214-9. doi: 10.3109/13880209.2014.970289. Epub 2015 Jan 22.

PMID:
25609146
16.

Resistance of Schistosoma mansoni to praziquantel: is there a problem?

Doenhoff MJ, Kusel JR, Coles GC, Cioli D.

Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):465-9. Review.

PMID:
12474468
17.

Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.

Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL.

Am J Trop Med Hyg. 1996 Aug;55(2):214-8.

PMID:
8780463
18.

Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni.

Mattos AC, Pereira GC, Jannotti-Passos LK, Kusel JR, Coelho PM.

Acta Trop. 2007 May;102(2):84-91. Epub 2007 Apr 6.

PMID:
17498638
19.
20.

Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.

Liang YS, Coles GC, Dai JR, Zhu YC, Doenhoff MJ.

J Helminthol. 2002 Dec;76(4):327-33.

PMID:
12498638

Supplemental Content

Support Center